Epalrestat is an active pharmaceutical ingredient used as an aldose reductase inhibitor. It is a polymorphic compound studied for its color variations and structural differences in crystalline forms.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Epalrestat?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Halofuginone lactate
pharmaceutical raw material
Lumefantrine
pharmaceutical raw material
Erythromycin f
pharmaceutical raw material
Atomoxetine hydrochloride
pharmaceutical raw material
The international HS code for Epalrestat (CAS 82159-09-9) is 2934.10.
2934.10
2934 10 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-[(5Z)-5-[(E)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid
CHNUOJQWGUIOLD-NFZZJPOKSA-N
C/C(=C\C1=CC=CC=C1)/C=C\2/C(=O)N(C(=S)S2)CC(=O)O
Sourcing Epalrestat?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.